Home › Non-Small Cell Lung Cancer › Arizona › Gilbert
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Gilbert, AZ
Isang pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Gilbert. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1
- Banner MD Anderson Cancer Center, Gilbert
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Nagre-recruitPhase 3
- Banner MD Anderson Cancer Center ( Site 0181), Gilbert
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
Nagre-recruitPhase 1
- Research Site, Gilbert
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Nagre-recruitObservasyonal na pag-aaral
- Banner Health, Gilbert
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Nagre-recruitPhase 3
- Ironwood Cancer & Research Centers, Gilbert
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Nagre-recruitPhase 1/2
- Banner MD Anderson Cancer Center, Gilbert
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Nagre-recruitPhase 1/2
- Banner Health- MD Anderson Cancer Center, Gilbert
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Nagre-recruitPhase 3
- Banner MD Anderson Cancer Center, Gilbert
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Nagre-recruitPhase 3
- Research Site, Gilbert
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC
Nagre-recruitPhase 1/2
- Banner MD Anderson Cancer Center, Gilbert
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Nagre-recruitPhase 2
- Banner Health MD Anderson, Gilbert
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- Banner Health, Gilbert
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Nagre-recruitPhase 1/2
- Banner MD Anderson Cancer Center, Gilbert
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Gilbert
- Kanser sa Suso10 pag-aaral
- Colorectal Cancer9 pag-aaral
- Kanser (lahat ng uri)8 pag-aaral
- Kanser sa Baga8 pag-aaral
- Kanser sa Pantog6 pag-aaral
- Pagkabigo ng Puso6 pag-aaral
- Multiple Myeloma6 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg6 pag-aaral
- Sakit sa Puso at Ugat ng Dugo6 pag-aaral
- Metastatic Cancer6 pag-aaral
- Diffuse Large B-Cell Lymphoma5 pag-aaral
- Non-Hodgkin Lymphoma5 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.